Enlivex Therapeutics Ltd.
ENLV | NASDAQ
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.29
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 6:29 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 214K | 242K | 332K | 292K | 372K | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 476K | 411K | 349K |
Gross Profit | -214K | -242K | -332K | -292K | -372K | -447K | -545K | -709K | -762K | -814K | -835K | -856K | -834K | -798K | -777K | -706K | -671K | -617K | -546K | -476K | -411K | -349K |
Operating Income | -20.56M | -19.41M | -15.03M | -14.8M | -15.36M | -15.27M | -15.69M | -20.39M | -22.9M | -26.56M | -29.4M | -26.91M | -26.95M | -26.18M | -25.8M | -25.77M | -23.95M | -21.89M | -19.29M | -15.17M | -13.27M | -11.69M |
Interest Income | 660K | 1.85M | 1.93M | 2.1M | 2.26M | 1.05M | 984K | 528K | 11K | 11.42K | 422 | 422 | 422 | n/a | n/a | 120K | 120K | 820K | 1.42M | 1.53M | 1.58M | 973K |
Pretax Income | 5.35B | 2.89B | 1.62B | -12.7M | -13.1M | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Net Income | 4.11B | 2.21B | 1.24B | -12.7M | -13.1M | -14.33M | -15.01M | -18.93M | -22.29M | -25.99M | -29.07M | -27.16M | -26.93M | -30.05M | -31.06M | -28.61M | -26.3M | -19.49M | -14.47M | -15.6M | -14.3M | -14.23M |
Selling & General & Admin | 9.71M | 9.33M | 5.69M | 4.92M | 4.62M | 4.67M | 4.81M | 3.58M | 4.09M | 4.72M | 5.23M | 6.24M | 6.44M | 6.59M | 6.7M | 7.44M | 7.15M | 6.66M | 6.24M | 5.21M | 4.78M | 4.38M |
Research & Development | 10.75M | 9.97M | 9.2M | 9.59M | 10.46M | 10.32M | 10.62M | 11.66M | 13.66M | 16.69M | 19.01M | 20.26M | 20.11M | 19.19M | 18.69M | 18.16M | 16.64M | 15.07M | 12.88M | 9.87M | 8.39M | 7.21M |
Other Expenses | -103K | -131K | -102K | 119K | 200K | 285K | 457K | 5.35M | 5.35M | 5.35M | 5.15M | 402K | 402K | 402K | 402K | 167K | 167K | 167K | 167K | 97K | 97K | 97K |
Operating Expenses | 20.35M | 19.17M | 14.79M | 14.63M | 15.28M | 15.27M | 15.89M | 20.59M | 23.1M | 26.76M | 29.4M | 26.91M | 26.95M | 26.18M | 25.8M | 25.77M | 23.95M | 21.89M | 19.29M | 15.17M | 13.27M | 11.69M |
Interest Expense | 1.33M | n/a | n/a | n/a | n/a | 110K | 110K | 110K | 445K | 335K | 770K | 114K | -165K | 3.88M | 5.26M | 5.92M | 5.86M | 1.82M | n/a | n/a | 223K | 1.12M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.56M | 19.41M | 15.03M | 14.8M | 15.36M | 15.27M | 15.69M | 20.39M | 22.9M | 26.56M | 29.4M | 26.91M | 26.95M | 26.18M | 25.8M | 25.77M | 23.95M | 21.89M | 19.29M | 15.17M | 13.27M | 11.69M |
Income Tax Expense | 1.24B | 676.29M | 382.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.03M | 1.12M | 189.36K | 100.19K | 99.4K | 91.23K | 91.23K | 88.66K | 81.44K | 78.03K | 77.49K | 77.49K | 77.44K | 77.15K | 76.76K | 76.63K | 76.56K | 76.54K | 76.3K | 76.3K | 76.28K | 68.67K |
Shares Outstanding (Diluted) | 1.21M | 1.12M | 200.83K | 100.19K | 99.4K | 91.23K | 91.23K | 88.66K | 81.44K | 78.03K | 77.49K | 77.49K | 77.44K | 77.15K | 76.76K | 76.63K | 76.56K | 76.54K | 76.3K | 76.3K | 76.28K | 68.67K |
EPS (Basic) | 9.24K | 7.39K | 6.48K | -136.80 | -143.52 | -163.20 | -177.60 | -237.60 | -285.60 | -336 | -374.40 | -340.80 | -338.40 | -432 | -472.80 | -451.20 | -422.40 | -280.80 | -194.40 | -237.60 | -230.40 | -244.80 |
EPS (Diluted) | 8.6K | 7.02K | 6.11K | -136.80 | -143.52 | -163.20 | -177.60 | -237.60 | -285.60 | -336 | -374.40 | -340.80 | -338.40 | -432 | -472.80 | -451.20 | -422.40 | -280.80 | -194.40 | -237.60 | -230.40 | -244.80 |
EBITDA | -19.93M | -18.76M | -14.32M | -13.67M | -14.51M | -14.34M | -14.69M | -15.44M | -17.89M | -21.5M | -24.32M | -26.05M | -26.12M | -25.38M | -25.02M | -25.06M | -23.28M | -21.27M | -18.74M | -14.89M | -13.07M | -11.55M |
EBIT | -20.21M | -19.06M | -14.65M | -13.96M | -14.88M | -14.79M | -15.23M | -16.15M | -18.66M | -22.32M | -25.15M | -26.91M | -26.95M | -26.18M | -25.8M | -25.77M | -23.95M | -21.89M | -19.29M | -15.38M | -13.48M | -11.9M |
Depreciation & Amortization | 278K | 302.5K | 332K | 292K | 372K | 447K | 545K | 709K | 762K | 814K | 835K | 856K | 834K | 798K | 777K | 706K | 671K | 617K | 546K | 496K | 411K | 349K |
Add to Watchlist
Select watchlists to add or remove ENLV